Rather than a research prospectus, the new review presents our vision, key facts and figures about the Institute and our performance in 2021 and 2022, shares highlights and recognises the achievements of people who received awards, before providing updates from each of our three research programmes: Immunology, Signalling and Epigenetics. Five spotlight features (highlighted below) bring the Institute’s research to life, focusing on individual research groups, particularly those new to the Institute, and exploring their work in relation to the Institute’s central mission of undertaking world-leading research to deliver lifelong health.
You can browse the 2021-2022 research report using the reader below or download the PDF version in full. The downloadable pdf file includes the following accessibility features: alternative text for images and symbols, auto tagging, and a manually curated reading order to ensure that screen readers follow a logical reading order. If you have any questions about the report or feedback on how the accessibility of the report can be improved, please contact comms@babraham.ac.uk.
Joining a new organisation and building your research team during a pandemic isn’t ideal but new group leader Dr Ian McGough is pleased he’s found his niche, and gorgeous trail running routes, alongside a very warm welcome.
Dr Philipp Voigt joined the Institute in December 2021 to set up a new group in the Epigenetics programme. But on leaving school he wanted to teach maths and Latin. Here, he explains the biological conundrums he aims to answer – and why Latin grammar could yet come in handy.
Dr Arianne Richard talks about T cells, how knowing more about how they operate could open up new vaccines against viruses and new therapies for cancer, and why the Institute is the best place for her to tackle these questions.
Dr Della David reflects on her first 12 months at the Institute, reveals the roots of her own scientific curiosity, and explains how a tiny, transparent, short-lived worm is enabling her to discover new ways of promoting healthy ageing.
Dr Peter Rugg-Gunn talks about the challenges of studying early human development, his group’s groundbreaking discoveries, and why he believes the Human Development Biology Initiative – a five year, £10m project funded by Wellcome – will lead to a step change in the field.